A magnetic particle-based enzyme-catalyzed chemiluminescent immunoassay reagent for the detection of testosterone
Testicular binding is resolved by using magnetic particles enzymatic chemiluminescence immunoassay reagents containing superparamagnetic particles coated with testicular antigen and alkaline phosphatase-labeled testicular antibody in testicular immunoassay, combined with specific release agents The problem of difficulty in protein dissociation improves the sensitivity and specificity of detection.
Patent Information
- Application Number
- CN202110892227.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-08-04
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2041-08-04
AI Technical Summary
Existing testosterone immunoassay technology is difficult to effectively release testosterone from sex hormone-binding proteins, albumin and cortisol-binding proteins, affecting the sensitivity and specificity of the detection.
A testosterone magnetic particle enzymatic chemiluminescence immunoassay reagent, containing 0.01-0.05% superparamagnetic particles coated with testosterone antigen, alkaline phosphatase-labeled testosterone antibody, testosterone release reagent and alkaline phosphatase The luminescent substrate is used to quickly dissociate the testicular cheesy protein by combining dihydrotestic, danazole, heparin sodium, 8-aniline-1-naphthalenesulfonic acid and other testicular cheesy protein.
It significantly improves the sensitivity and specificity of the testicular and cheese immunoassay reagent, making the testicular and cheese detection more accurate.
Smart Images

Figure CN113624982B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of immunoassay, and in particular to a magnetic particle enzymatic chemiluminescent immunoassay reagent for testosterone. Background Art
[0002] Testosterone, also known as testosterone, testosterone or testosterone, is a steroid estrogen secreted by the male testicles or female ovaries. The adrenal glands also secrete a small amount of testosterone. Testosterone can promote the formation of epididymis, vas deferens and seminal vesicles, promote the growth and development of external reproductive organs and secondary sexual characteristics, and affect the production of sperm. It has an important impact on health for both men and women. For men, increased testosterone levels are common in adrenal cortical hyperplasia, adrenal cortical tumors, testicular tumors, male precocious puberty and other diseases. Reduced testosterone levels are common in primary male dysfunction such as cryptorchidism, anorchia, interstitial cell dysgenesis, congenital seminiferous tubule dysgenesis, as well as hyperprolactinemia, hypercortisolism and other diseases. For women, abnormal testosterone levels are common in diseases such as idiopathic hirsutism, polycystic ovary syndrome, pineal tumors, and ovarian masculinization tumors. Accurate detection of testosterone levels in the body can help assist in the diagnosis and treatment of these diseases.
[0003] In serum, testosterone is mainly bound to sex hormone binding protein, albumin and cortisol binding protein, and only 2% of testosterone is in a free state. The immunoassay of serum total testosterone requires the release of testosterone from sex hormone binding protein, albumin and cortisol binding protein to facilitate antibody recognition. Therefore, the formula composition of the testosterone release reagent in the detection reagent is related to the release effect of testosterone, which directly affects the sensitivity and specificity of the serum total testosterone immunoassay reagent. Summary of the invention
[0004] In view of the problems raised by the above background technology, the purpose of the present invention is to provide a magnetic particle enzymatic chemiluminescent immunoassay reagent for testosterone.
[0005] In order to achieve the above technical objectives, the technical solution adopted by the present invention is as follows:
[0006] A magnetic particle enzymatic chemiluminescent immunoassay reagent for testosterone, comprising the following components: 0.01-0.05% superparamagnetic particles coated with testosterone antigen, alkaline phosphatase-labeled testosterone antibody, testosterone releasing reagent, alkaline phosphatase luminescent substrate and magnetic bead cleaning solution;
[0007] The testosterone releasing agent is one or more combinations of dihydrotestosterone, danazol, sodium heparin, 8-aniline-1-naphthalenesulfonic acid (ANS), 8-aniline-1-naphthalenesulfonate, sodium trichloroacetate, 2-Hydroxymethyleneethisterone (CAS: 2787-02-2), ethisterone (CAS: 434-03-7), and 2-Hydroxymethyl-1,2-dehydroethisterone (CAS: 60142-08-7).
[0008] As a preferred embodiment of the present invention, the concentrations of the components in the testosterone releasing agent are as follows: the concentration of dihydrotestosterone is 0.01-0.05 mg / mL, the concentration of danazol is 0.05-0.5 mg / mL, the concentration of heparin sodium is 2-50 mg / mL, the concentration of 8-aniline-1-naphthalenesulfonic acid (ANS) or 8-aniline-1-naphthalenesulfonic acid salt is 1-5 mg / mL, the concentration of sodium trichloroacetate is 1-25 mg / mL, the concentration of ethinyl progesterone is 0.05-0.25 mg / mL, the concentration of 2-Hydroxymethylene Ethisterone (CAS: 2787-02-2) is 0.01-0.5 mg / mL, and the concentration of 2-Hydroxymethyl-1,2-dehydroethisterone is 0.01-0.60 mg / mL;
[0009] The preparation method of the testosterone releasing reagent is:
[0010] S1: Take a compound having the function of releasing testosterone according to the composition ratio, dissolve it with DMSO or DMF or pure water to prepare a mother solution with a concentration of 500 mg / mL.
[0011] S2: diluting the solution to a corresponding concentration using a buffer solution to prepare a testosterone releasing reagent.
[0012] 3. A magnetic particle enzymatic chemiluminescent immunoassay reagent for testosterone according to claim 2, characterized in that: in S2, the buffer is one of PBS buffer, morpholinoethanesulfonic acid buffer (MES), Tris-HCL buffer, citrate buffer, 3-(N-morpholino)-2-hydroxypropanesulfonic acid (MOPSO) buffer, glycine-hydrochloric acid buffer, acetic acid-sodium acetate buffer, 4-hydroxyethylpiperazineethanesulfonic acid (HEPES), and TRIS buffer.
[0013] As a preferred embodiment of the present invention, the preparation method of the superparamagnetic particles coated with testosterone antigen is as follows:
[0014] A1: Take 1 mL of commercial carboxyl magnetic beads (10 mg / mL) into a 2.0 mL centrifuge tube, place the centrifuge tube on a magnetic separator for magnetic separation, and remove the supernatant;
[0015] A2: Add 1 mL of labeling buffer (0.1 M MES, pH 5.0) to the centrifuge tube, resuspend the magnetic beads, place on a magnetic separator for magnetic separation, and remove the supernatant;
[0016] A3: Add 1 mL of labeling buffer to the centrifuge tube and vortex to mix to resuspend the magnetic beads;
[0017] A4: Add 100ul of testosterone antigen (testosterone-BSA conjugate) to the resuspended magnetic beads and rotate and mix at room temperature for 30 minutes;
[0018] A5: Add 100 μl of coupling agent EDC (10 mg / mL, prepared in labeling buffer) to the mixture of magnetic beads and testosterone antigen, shake and mix well, and rotate and mix at room temperature for 3 h;
[0019] A6: After the reaction is completed, place the centrifuge tube on a magnetic separator for magnetic separation. After removing the supernatant, add 1 ml of magnetic bead washing buffer (25 mM Tris-HCL, 150 mM NaCl, 0.05% Tween 20, pH 7.2), shake and mix, then place it on a magnetic separator for magnetic separation and remove the supernatant. Repeat the magnetic bead washing 3 times;
[0020] A7: After the last step of washing is completed, add 500ul of magnetic bead storage buffer (50mMTris, 150mMNaCl, 1% BSA, 0.05% PC300, pH7.2), resuspend the magnetic beads and store in a refrigerator.
[0021] As a preferred embodiment of the present invention, the preparation method of the alkaline phosphatase labeled testosterone antibody is as follows:
[0022] B1: Take an appropriate amount of alkaline phosphatase and dissolve it in 0.8 ml of pure water. Add 0.2 ml of freshly prepared 0.1 M NaI04 solution to the alkaline phosphatase and react at room temperature in the dark for 20 min.
[0023] B2: Add the above buffer to a 10KD ultrafiltration centrifuge tube, ultrafiltration centrifuge at 4 degrees, and replace the buffer with pH 9.5, 0.2M carbonate buffer;
[0024] B3: Add a certain amount of testosterone antibody to the alkaline phosphatase after replacing the buffer, and react at room temperature in the dark for 3 hours;
[0025] B4: Add 0.1 ml of freshly prepared 4 mg / mL sodium borohydride solution, mix well and let stand at 4 degrees for 2 hours;
[0026] B5: After the reaction is completed, ultrafiltration centrifugation is performed using a 50kD ultrafiltration centrifuge tube, and buffer replacement is performed using 50mM PBS buffer at pH 7.4 to obtain alkaline phosphatase-labeled testosterone antibody.
[0027] As a preferred embodiment of the present invention, the alkaline phosphatase luminescent substrate contains 50mM Tris, 0.5mM MAPS-5, 5mM MgCl2, 2.5mM ZnCl2, 0.1% TritonX100, and 0.05% Proclin 300, and the pH value of the alkaline phosphatase luminescent substrate is 9.5±0.2.
[0028] By adopting the technical solution of the present invention,
[0029] Compared with the prior art, the release agent in the detection reagent of the present invention, as a component of the testosterone enzymatic chemiluminescent immunoassay reagent, can quickly and effectively dissociate testosterone from its binding protein, so that the sensitivity and specificity of the testosterone immunoassay reagent can be significantly improved. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] The present invention can be further illustrated by the non-limiting examples given in the accompanying drawings;
[0031] Figure 1 This is a test result diagram of a reference example without a testosterone-releasing reagent;
[0032] Figure 2 Example 1 test result diagram;
[0033] Figure 3 Example 2 test result diagram;
[0034] Figure 4 Example 3 test result diagram;
[0035] Figure 5 Example 4 test result diagram;
[0036] Figure 6 Example 5 test result diagram. DETAILED DESCRIPTION
[0037] In order to enable those skilled in the art to better understand the present invention, the technical solution of the present invention is further described below in conjunction with the accompanying drawings and embodiments.
[0038] A magnetic particle enzymatic chemiluminescent immunoassay reagent for testosterone, comprising: 0.01-0.05% superparamagnetic particles coated with testosterone antigen, alkaline phosphatase-labeled testosterone antibody, testosterone releasing reagent, alkaline phosphatase luminescent substrate and magnetic bead cleaning solution;
[0039] The testosterone releasing agent is one or more combinations of dihydrotestosterone, danazol, sodium heparin, 8-aniline-1-naphthalenesulfonic acid (ANS), 8-aniline-1-naphthalenesulfonate, sodium trichloroacetate, 2-Hydroxymethylene Ethisterone (CAS: 2787-02-2), ethisterone (CAS: 434-03-7), and 2-Hydroxymethyl-1,2-dehydroethisterone (CAS: 60142-08-7).
[0040] The preparation method of superparamagnetic particles coated with testosterone antigen is as follows:
[0041] A1: Take 1 mL of commercial carboxyl magnetic beads (10 mg / mL) into a 2.0 mL centrifuge tube, place the centrifuge tube on a magnetic separator for magnetic separation, and remove the supernatant;
[0042] A2: Add 1 mL of labeling buffer (0.1 M MES, pH 5.0) to the centrifuge tube, resuspend the magnetic beads, place on a magnetic separator for magnetic separation, and remove the supernatant;
[0043] A3: Add 1 mL of labeling buffer to the centrifuge tube and vortex to mix to resuspend the magnetic beads;
[0044] A4: Add 100ul of testosterone antigen (testosterone-BSA conjugate) to the resuspended magnetic beads and rotate and mix at room temperature for 30 minutes;
[0045] A5: Add 100 μl of coupling agent EDC (10 mg / mL, prepared in labeling buffer) to the mixture of magnetic beads and testosterone antigen, shake and mix well, and rotate and mix at room temperature for 3 h;
[0046] A6: After the reaction is completed, place the centrifuge tube on a magnetic separator for magnetic separation, remove the supernatant, add 1 ml of magnetic bead washing buffer (25 mM Tris-HCL, 150 mM NaCl, 0.05% Tween 20, pH 7.2), shake and mix, place it on a magnetic separator for magnetic separation, and remove the supernatant. Repeat the magnetic bead washing 3 times;
[0047] A7: After the last step of washing is completed, add 500ul of magnetic bead storage buffer (50mMTris, 150mMNaCl, 1% BSA, 0.05% PC300, pH7.2), resuspend the magnetic beads and store in a refrigerator.
[0048] The preparation method of alkaline phosphatase labeled testosterone antibody is as follows:
[0049] B1: Take an appropriate amount of alkaline phosphatase and dissolve it in 0.8 ml of pure water. Add 0.2 ml of freshly prepared 0.1 M NaI04 solution to the alkaline phosphatase and react at room temperature in the dark for 20 min.
[0050] B2: Add the above buffer to a 10KD ultrafiltration centrifuge tube, ultrafiltration centrifuge at 4 degrees, and replace the buffer with pH 9.5, 0.2M carbonate buffer;
[0051] B3: Add a certain amount of testosterone antibody to the alkaline phosphatase after replacing the buffer, and react at room temperature in the dark for 3 hours;
[0052] B4: Add 0.1 ml of freshly prepared 4 mg / mL sodium borohydride solution, mix well and let stand at 4 degrees for 2 hours;
[0053] B5: After the reaction is completed, ultrafiltration centrifugation is performed using a 50kD ultrafiltration centrifuge tube, and buffer replacement is performed using 50mM PBS buffer at pH 7.4 to obtain alkaline phosphatase-labeled testosterone antibody.
[0054] The alkaline phosphatase luminescent substrate contains 50 mM Tris, 0.5 mM AP S-5, 5 mM MgCl2, 2.5 mM ZnCl2, 0.1% TritonX100, and 0.05% Proclin 300, and the pH value of the alkaline phosphatase luminescent substrate is 9.5±0.2.
[0055] Example 1: A magnetic particle enzymatic chemiluminescent immunoassay reagent for testosterone, comprising: 0.01-0.05% superparamagnetic particles coated with testosterone antigen, alkaline phosphatase labeled testosterone antibody, testosterone releasing reagent, alkaline phosphatase luminescent substrate and magnetic bead cleaning solution,
[0056] wherein superparamagnetic particles coated with testosterone antigen, alkaline phosphatase labeled testosterone antibody and alkaline phosphatase luminescent substrate are prepared according to the above method;
[0057] The testosterone release reagent contains 0.02 mg / mL dihydrotestosterone, 0.1 mg / mL danazol, 50 mM PBS buffer, pH 7.0.
[0058] Example 2: The difference from Example 1 is that the testosterone releasing reagent contains 3.0 mg / mL sodium trichloroacetate, 0.1 mg / mL ethinyl progesterone, 100 mM TRIS buffer, pH 7.4.
[0059] Example 3: The difference from Example 1 is that the testosterone releasing reagent contains 4.0 mg / mL heparin sodium, 0.03 mg / mL dihydrotestosterone, 2 mg / mL 8-aniline-1-naphthalenesulfonic acid (ANS), 60 mM Tris-HCL buffer, and the pH is adjusted to 7.2.
[0060] Example 4: The difference from Example 1 is that the testosterone releasing reagent contains 3.0 mg / mL sodium trichloroacetate, 0.1 mg / mL 2-Hydroxymethylene Ethisterone (CAS: 2787-02-2), 0.02 mg / mL dihydrotestosterone, 50 mM MES buffer, and the pH is adjusted to 6.0.
[0061] Example 5: The difference from Example 1 is that the testosterone releasing reagent contains 0.05 mg / mL of dihydrotestosterone, 0.1 mg / mL of 2-Hydroxymethylene Ethisterone (CAS: 2787-02-2), 2 mg / mL of 8-aniline-1-naphthalenesulfonic acid (ANS), 50 mM HEPES buffer, and the pH is adjusted to 8.0.
[0062] Specificity: 100 clinical samples were collected and assigned with the Roche testosterone kit. The samples were tested with the detection reagents obtained in the above five different embodiments. The test results were compared with the Roche test results. Figure 1-Figure 6 ;
[0063] Figure 1 This is a test result diagram of a reference example without a testosterone-releasing reagent. Figure 2-Figure 6 They are the test result diagrams of Example 1 to Example 5,
[0064] Figure 1 The experimental results show that the equation of the straight line is y = 0.8952x + 0.4372, and the correlation coefficient is R 2 =0.7812;
[0065] Figure 2 The experimental results show that the equation of the straight line is y = 1.0358x + 0.0112, and the correlation coefficient is R 2 =0.9743;
[0066] Figure 3 The experimental results show that the equation of the straight line is y = 1.0031x + 0.0063, and the correlation coefficient is R 2 =0.9759;
[0067] Figure 4 The experimental results show that the equation of the straight line is y = 0.9749x + 0.0700, and the correlation coefficient is R2 =0.9783;
[0068] Figure 5 The experimental results show that the equation of the straight line is y = 1.0001x + 0.0319, and the correlation coefficient is R 2 =0.9766;
[0069] Figure 6 The experimental results show that the equation of the straight line is y = 1.0453x + 0.0146, and the correlation coefficient is R 2 =0.9803.
[0070] pass Figure 1 and Figure 2-Figure 6 By comparison, we found that the detection reagent can quickly and effectively dissociate testosterone from its binding protein, so that the sensitivity and specificity of the testosterone immunoassay reagent can be significantly improved.
[0071] The above embodiments are merely illustrative of the principles and effects of the present invention, and are not intended to limit the present invention. Anyone familiar with the technology may modify or change the above embodiments without violating the spirit and scope of the present invention. Therefore, all equivalent modifications or changes made by those with ordinary knowledge in the technical field without departing from the spirit and technical ideas disclosed by the present invention should still be covered by the claims of the present invention.
Claims
1. A magnetic particle enzymatic chemiluminescent immunoassay reagent for testosterone, characterized in that: The composition comprises: 0.01-0.05% superparamagnetic particles coated with testosterone antigen, alkaline phosphatase labeled testosterone antibody, testosterone releasing reagent, alkaline phosphatase luminescent substrate and magnetic bead cleaning solution; the testosterone releasing reagent is a combination of 0.05 mg / mL dihydrotestosterone, 2.0 mg / mL 8-aniline-1-naphthalenesulfonic acid and 0.1 mg / mL 2-Hydroxymethylene Ethisterone.
